Insurance Coverage: Many major insurance plans no longer cover Sovaldi starting in 2016. Learn More
Elizabeth Davis - January 28, 2016
The new Goodrx Top 10 Lists are in, and this time we take a look back at the end of 2015. These are the most popular and most expensive drugs in the US, and they cover all kinds of conditions from common heart and pain meds to pricey treatments for cancer and genetic disorders.
To start with—which drugs were filled the most in the last quarter of 2015?
Elizabeth Davis - October 08, 2015
With all the news about high drug prices recently—which drugs are actually costing Americans the most money? What about the prescriptions that are being used the most? Take a look, and we’ll guide you through the highlights of the new GoodRx Top 10s, based on a sample of claims reported by pharmacies across the country.
Which drugs are the most expensive?
- Treatments for rare diseases make up a good portion of the list, particularly for hereditary angioedema (HAE). See More
The GoodRx Pharmacist - September 30, 2015
If you’ve been following the news, huge price increases on necessary drugs like Daraprim and cycloserine may seem unusual—they both dropped in price again once people noticed and complained, right?
The unfortunate reality as that price increases happen in the pharmaceutical industry day-in and day-out. While the majority aren’t quite as dramatic as the Daraprim price hike, they happen more often than you might think. See More
Elizabeth Davis - August 12, 2015
It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.
Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More
Elizabeth Davis - June 05, 2015
Our new top 10 lists are in for the most-dispensed and most expensive prescriptions in the US—take a look at these interesting updates.
Which prescriptions have been filled the most in 2015 so far?
Based on a sample of claims reported by pharmacies across the country, thyroid meds like Synthroid and levothyroxine near the top of the list, while standard heart and diabetes prescriptions lisinopril (Zestril, Prinivil), atorvastatin (Lipitor), and metformin (Glucophage) are still very frequently prescribed—no surprises there. See More
The GoodRx Pharmacist - March 24, 2015
When you pick up your medications at the pharmacy you may notice that they are typically dispensed in amber colored vials or plastic containers. You may or may not be aware that these amber colored vials are not the original bottle the manufacturer dispensed the medication in.
For the majority of medications, transferring them from the manufacturer’s original bottle to the pharmacy’s amber vials is not a big deal, and lets the pharmacy purchase in bulk (which is more cost-effective)—unless you are taking certain medications. See More
Elizabeth Davis - February 06, 2015
We’ve updated our lists of the Top 10 most-dispensed and most expensive prescriptions in the US, with some interesting changes from the end of 2014.
Curious about the most popular prescriptions?
Based on a sample of claims reported by pharmacies across the country, some common antibiotics, like amoxicillin (Amoxil) and azithromycin (Zithromax) top the list, along with heart meds like atorvastatin (Lipitor) and lisinopril (Zestril, Prinivil). See More
The GoodRx Pharmacist - January 14, 2015
In the past year, the realm of hepatitis C treatment has been flourishing. Several new medications have received FDA approval and have changed the way we treat this often silent disease.
With the introduction of new first line treatments, slowly but surely, we will begin to see the discontinuation of many older hepatitis C treatments. Incivek was pulled by its manufacturer, Vertex Pharmaceuticals, back in October. See More
The GoodRx Pharmacist - January 05, 2015
Viekira Pak was approved by the FDA on December 19, 2015 as the newest treatment for chronic hepatitis C (genotype 1), and is already available to patients. Genotype 1 is the most common in the US, affecting around 75% of Americans with the virus.
Were there any special circumstances for the approval of Viekira Pak?